Tyra Biosciences, Inc. TYRA Personnel Costs — Research And Development Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s personnel costs — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s personnel costs — research and development expense?
- Tyra Biosciences, Inc. (TYRA) reported personnel costs — research and development expense of $11.79M in Q1 2026.
- How has Tyra Biosciences, Inc.'s personnel costs — research and development expense changed year-over-year?
- Tyra Biosciences, Inc.'s personnel costs — research and development expense increased by 46.9% year-over-year, from $8.02M to $11.79M.
- What is the long-term trend for Tyra Biosciences, Inc.'s personnel costs — research and development expense?
- Over 2 years (2023 to 2025), Tyra Biosciences, Inc.'s personnel costs — research and development expense has grown at a 34.4% compound annual growth rate (CAGR), from $20.04M to $36.22M.
- What does personnel costs — research and development expense mean?
- This metric represents the total compensation and benefits-related expenditures allocated to personnel directly involved in research and development activities. It reflects the company's investment in human capital required to drive its drug discovery pipeline and clinical development programs. Tracking this expense provides insight into the organization's capacity to execute its scientific strategy and the scale of its internal innovation efforts.